Galecto Inc (GLTO)
0.7888
+0.01
(+1.13%)
USD |
NASDAQ |
Mar 28, 16:00
0.7888
0.00 (0.00%)
After-Hours: 20:00
Galecto Cash from Operations (TTM): -36.91M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -36.91M |
September 30, 2023 | -36.88M |
June 30, 2023 | -38.28M |
March 31, 2023 | -45.27M |
December 31, 2022 | -42.93M |
September 30, 2022 | -49.31M |
June 30, 2022 | -48.62M |
Date | Value |
---|---|
March 31, 2022 | -44.95M |
December 31, 2021 | -52.31M |
September 30, 2021 | -49.00M |
June 30, 2021 | -48.41M |
March 31, 2021 | -44.38M |
December 31, 2020 | -38.20M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-52.31M
Minimum
Dec 2021
-36.88M
Maximum
Sep 2023
-44.27M
Average
-44.95M
Median
Mar 2022
Cash from Operations (TTM) Benchmarks
Novo Nordisk A/S | 15.81B |
Genmab A/S | 1.071B |
Ascendis Pharma A/S | -505.97M |
Evaxion Biotech AS | -- |
IO Biotech Inc | -71.74M |